levonorgestrel has been researched along with ortho evra in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, N | 1 |
| Hagberg, KW; Hernandez, RK; Jick, SS; Kaye, JA | 1 |
| Weisberg, E | 1 |
| Bateson, D; Briggs, P; McNamee, K | 1 |
| Archer, DF; Foegh, M; Kaunitz, AM; Mishell, DR | 1 |
| Nelson, AL | 1 |
2 review(s) available for levonorgestrel and ortho evra
| Article | Year |
|---|---|
Advances in hormonal contraception.
Topics: Administration, Cutaneous; Administration, Intravaginal; Contraceptive Agents, Female; Contraceptives, Postcoital; Delayed-Action Preparations; Drug Combinations; Ethinyl Estradiol; Female; Humans; Injections, Subcutaneous; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Norgestrel | 2006 |
Transdermal contraception methods: today's patches and new options on the horizon.
Topics: Administration, Cutaneous; Animals; Clinical Trials, Phase III as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes | 2015 |
1 trial(s) available for levonorgestrel and ortho evra
| Article | Year |
|---|---|
Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Obesity; Patient Outcome Assessment; Transdermal Patch; Young Adult | 2015 |
3 other study(ies) available for levonorgestrel and ortho evra
| Article | Year |
|---|---|
Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism.
Topics: Adolescent; Adult; Case-Control Studies; Confidence Intervals; Contraceptives, Oral; Databases, Factual; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Norgestrel; Odds Ratio; Product Surveillance, Postmarketing; United States; Venous Thromboembolism | 2010 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
Newer non-oral hormonal contraception.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Drug Implants; Drug Monitoring; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Safety; Treatment Outcome | 2013 |